ATE256661T1 - Bispiperidine mit antithrombotischer wirkung - Google Patents
Bispiperidine mit antithrombotischer wirkungInfo
- Publication number
- ATE256661T1 ATE256661T1 AT99929495T AT99929495T ATE256661T1 AT E256661 T1 ATE256661 T1 AT E256661T1 AT 99929495 T AT99929495 T AT 99929495T AT 99929495 T AT99929495 T AT 99929495T AT E256661 T1 ATE256661 T1 AT E256661T1
- Authority
- AT
- Austria
- Prior art keywords
- bispiperidine
- antithrombotic effect
- antithrombotic
- therepeutically
- fibrinogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Materials For Medical Uses (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809166A FR2781223B1 (fr) | 1998-07-17 | 1998-07-17 | Bispiperidines et leurs applications therapeutiques |
| PCT/FR1999/001745 WO2000003986A1 (fr) | 1998-07-17 | 1999-07-16 | Bispiperidines comme agents antithrombotiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE256661T1 true ATE256661T1 (de) | 2004-01-15 |
Family
ID=9528732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99929495T ATE256661T1 (de) | 1998-07-17 | 1999-07-16 | Bispiperidine mit antithrombotischer wirkung |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6333338B1 (de) |
| EP (1) | EP1098878B1 (de) |
| JP (1) | JP2002520393A (de) |
| KR (1) | KR100584032B1 (de) |
| CN (1) | CN1286812C (de) |
| AT (1) | ATE256661T1 (de) |
| AU (1) | AU761655B2 (de) |
| BR (1) | BR9912835A (de) |
| CA (1) | CA2337776A1 (de) |
| DE (1) | DE69913701T2 (de) |
| DK (1) | DK1098878T3 (de) |
| EA (1) | EA003674B1 (de) |
| ES (1) | ES2212576T3 (de) |
| FR (1) | FR2781223B1 (de) |
| HU (1) | HUP0103623A3 (de) |
| IL (2) | IL140581A0 (de) |
| NO (1) | NO318963B1 (de) |
| NZ (1) | NZ509170A (de) |
| PL (1) | PL193804B1 (de) |
| PT (1) | PT1098878E (de) |
| SK (1) | SK152001A3 (de) |
| TR (1) | TR200100159T2 (de) |
| UA (1) | UA65631C2 (de) |
| WO (1) | WO2000003986A1 (de) |
| ZA (1) | ZA200100238B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003519119A (ja) * | 1999-12-24 | 2003-06-17 | スミスクライン ビーチャム パブリック リミテッド カンパニー | (ヘテロ)ビシクリルメタンスルホニルアミノ置換ヒドロキサム酸誘導体 |
| JP4695591B2 (ja) * | 2003-06-18 | 2011-06-08 | アポセンス リミテッド | アポトーシス細胞を選択的に標的化する方法、および、それらに用いられる低分子物質リガンド |
| RS66218B1 (sr) | 2019-07-01 | 2024-12-31 | Tonix Pharma Ltd | Anti-cd154 antitela i njihove upotrebe |
| WO2022150452A1 (en) | 2021-01-06 | 2022-07-14 | Seth Lederman | Methods of inducing immune tolerance with modified anti-cd154 antibodies |
| WO2025248134A1 (en) | 2024-05-31 | 2025-12-04 | Tonix Pharma Limited | Treatment methods comprising administration of modified cd154 antibodies |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
-
1998
- 1998-07-17 FR FR9809166A patent/FR2781223B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-16 CA CA002337776A patent/CA2337776A1/en not_active Abandoned
- 1999-07-16 UA UA2001021081A patent/UA65631C2/uk unknown
- 1999-07-16 IL IL14058199A patent/IL140581A0/xx active IP Right Grant
- 1999-07-16 AU AU46290/99A patent/AU761655B2/en not_active Ceased
- 1999-07-16 AT AT99929495T patent/ATE256661T1/de not_active IP Right Cessation
- 1999-07-16 PT PT99929495T patent/PT1098878E/pt unknown
- 1999-07-16 EP EP99929495A patent/EP1098878B1/de not_active Expired - Lifetime
- 1999-07-16 ES ES99929495T patent/ES2212576T3/es not_active Expired - Lifetime
- 1999-07-16 DE DE69913701T patent/DE69913701T2/de not_active Expired - Fee Related
- 1999-07-16 TR TR2001/00159T patent/TR200100159T2/xx unknown
- 1999-07-16 DK DK99929495T patent/DK1098878T3/da active
- 1999-07-16 BR BR9912835-7A patent/BR9912835A/pt not_active Application Discontinuation
- 1999-07-16 CN CNB998097772A patent/CN1286812C/zh not_active Expired - Fee Related
- 1999-07-16 HU HU0103623A patent/HUP0103623A3/hu unknown
- 1999-07-16 NZ NZ509170A patent/NZ509170A/en unknown
- 1999-07-16 US US09/743,910 patent/US6333338B1/en not_active Expired - Fee Related
- 1999-07-16 WO PCT/FR1999/001745 patent/WO2000003986A1/fr not_active Ceased
- 1999-07-16 EA EA200100150A patent/EA003674B1/ru not_active IP Right Cessation
- 1999-07-16 PL PL99345418A patent/PL193804B1/pl not_active IP Right Cessation
- 1999-07-16 JP JP2000560094A patent/JP2002520393A/ja active Pending
- 1999-07-16 SK SK15-2001A patent/SK152001A3/sk unknown
- 1999-07-16 KR KR1020017000665A patent/KR100584032B1/ko not_active Expired - Fee Related
-
2000
- 2000-12-26 IL IL140581A patent/IL140581A/en not_active IP Right Cessation
-
2001
- 2001-01-09 ZA ZA200100238A patent/ZA200100238B/en unknown
- 2001-01-15 NO NO20010252A patent/NO318963B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199900598A1 (ru) | Производные 1-арил- и пиридилпиразола с пестицидными свойствами | |
| NO933999L (no) | Fibrinogenreseptorantagonister | |
| TR199701356A2 (xx) | L�kozit adhasyonu inhibit�rleri ve VLA-4-antagonistleri olarak heterosiklenler. | |
| PT892780E (pt) | Analogos de m-amidino fenilo como inibidores do factor xa | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| BR0208365A (pt) | Derivados de 2-amino-propanol | |
| ES2160408T3 (es) | Trifluorfenil-triazolpirimidinas fungicidas. | |
| TR200000782T2 (tr) | Resorsinol türevleri. | |
| DE69328072D1 (de) | Umweltfreundliche Zusammensetzungen zur Verbesserung des Viskositätsindexes | |
| BR0009421A (pt) | Inibidores de ligação lfa-1 aos icams e uso dos mesmos | |
| BG103558A (en) | Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| YU11401A (sh) | Lokalne farmaceutske kompozicije koje sadrže nimesulid | |
| ATE256661T1 (de) | Bispiperidine mit antithrombotischer wirkung | |
| SE9903290D0 (sv) | Novel compounds | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| ATE441642T1 (de) | Hydantoin derivate mit affinität für somatostatin rezeptoren | |
| TR200402343T4 (tr) | Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit | |
| EA200200798A1 (ru) | Кальцилитические соединения | |
| EA200100853A1 (ru) | Резорциновая композиция | |
| DE60043228D1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
| EA200100152A1 (ru) | Замещенные пиперазиноны и их терапевтическое применение | |
| EA200100151A1 (ru) | Производные пиперазинона и их применение | |
| EA200100299A1 (ru) | Уреидопиперидиновые производные как селективные антагонисты nk3 - рецепторов человека | |
| DE58909628D1 (de) | Verwendung von transferrin zur bekämpfung der toxischen wirkung des endotoxins bei der endotoxinämie | |
| EA199900959A1 (ru) | Способы снижения содержания фибриногена |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1098878 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |